One major drug company just put a cap on its insulin prices. What comes next?
07:45
Share this -
copied
In response to public and political pressure, and signs of a changing market, pharmaceutical giant Eli Lilly just announced that it will cap the out-of-pocket cost of Insulin at $35 per month. Bharat Ramamurti, the Deputy Director for the National Economic Council, attributes the announcement in part to consistent pressure from the Biden Administration. The shift will bring relief to some of the seven million Americans with diabetes who rely on daily insulin to survive. A 2021 survey showed that 1 in 5 Americans on insulin ration the medication to save money.March 5, 2023
UP NEXT
John Kasich advocates for “compromise” on abortion
06:12
Report: U.S. drug shortage increased nearly 30% from 2021 and 2022
05:13
John Kasich: Trump is a divider and will lose if he runs in 2024
04:47
Fmr. Rep. Holtzman: Trump “can’t stop the rule of law”
07:32
Fmr. FDIC Chair warns of ‘moral hazard’ in bank regulation process
05:59
Velshi: The FDIC should ensure all deposits to protect banks